Activating SRC mutation in a subset of advanced human colon cancers
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The discovery of Rous sarcoma virus (RSV) led to the identification of cellular Src (c-Src), a non-receptor tyrosine kinase, which has since been implicated in the development of numerous human cancers. c-Src has been found to be highly activated in colon cancers, particularly in those metastatic to the liver. Studies of the mechanism of c-Src regulation have suggested that c-Src kinase activity is downregulated by phosphorylation of a critical carboxy-terminal tyrosine (Tyr 530 in human c-Src, equivalent to Tyr 527 in chicken Src) and have implied the existence of activating mutations in this C-terminal regulatory region. We report here the identification of a truncating mutation in SRC at codon 531 in 12% of cases of advanced human colon cancer tested and demonstrate that the mutation is activating, transforming, tumorigenic and promotes metastasis. These results provide, for the first time, genetic evidence that activating SRC mutations may have a role in the malignant progression of human colon cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
CELLULAR FUNCTIONS REGULATED BY SRC FAMILY KINASES
Thomas, S. M., & Brugge, J. S. (1997) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.13.1.513 · Cited by 2,498
Three-dimensional structure of the tyrosine kinase c-Src
Xu, W., Harrison, S. C., & Eck, M. J. (1997) · Nature · doi:10.1038/385595a0 · Cited by 1,418
DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA
STEHELIN, D., VARMUS, H. E., BISHOP, J. M., & VOGT, P. K. (1976) · Nature · doi:10.1038/260170a0 · Cited by 1,321 · cited 1×
“We targeted this region for mutational screening because it is known to contain the principal regulatory phosphotyrosine (Tyr 530; Ref”
BackgroundIdentification of a transformation-specific antigen induced by an avian sarcoma virus
BRUGGE, J. S., & ERIKSON, R. L. (1977) · Nature · doi:10.1038/269346a0 · Cited by 888
Kmiecik, T. E., & Shalloway, D. (1987) · Cell · doi:10.1016/0092-8674(87)90756-2 · Cited by 623
Tyr 527 Is Phosphorylated in pp60 c- src : Implications for Regulation
Cooper, J. A., Gould, K. L., Cartwright, C. A., & Hunter, T. (1986) · Science · doi:10.1126/science.2420005 · Cited by 540 · cited 1×
“We targeted this region for mutational screening because it is known to contain the principal regulatory phosphotyrosine (Tyr 530; Ref”
BackgroundThe when and how of Src regulation
Cooper, J. A., & Howell, B. (1993) · Cell · doi:10.1016/0092-8674(93)90634-3 · Cited by 533
Tyrosine phosphorylation regulates the biochemical and biological properties of pp60c-src
Piwnica-Worms, H., Saunders, K. B., Roberts, T. M., Smith, A. E., & Cheng, S. H. (1987) · Cell · doi:10.1016/0092-8674(87)90757-4 · Cited by 520
Cell Transformation by the Viral src Oncogene
Jove, R., & Hanafusa, H. (1987) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.03.110187.000335 · Cited by 401
Self-citationIncrease in activity and level of pp60c-src in progressive stages of human colorectal cancer.
Talamonti, M. S., Roh, M. S., Curley, S. A., & Gallick, G. E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116200 · Cited by 399
Cited by
Items 401–500 of 507
Chicken sarcoma to human cancers: a lesson in molecular therapeutics.
Prakash, O., Bardot, S. F., & COLE, J. T. (2007) · PubMed Central · Cited by 3
Parent, L. J. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0016-5_28 · Cited by 3
Overview of Genetic Diagnosis in Cancer
Korf, B. R., & Mikhail, F. M. (2017) · Current Protocols in Human Genetics · doi:10.1002/cphg.36 · Cited by 4
Role of PTPRT in obesity and its substrate paxillin tyrosine-88 in colorectal cancer
Scott, A. J. (2014) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 2
Smith, K. A., Landon, A. C., Walberg, E. M., Fulton, D. C., Schrage, M. W., McCann, N. P., & Forester, J. D. (2025) · Conservation Science and Practice · doi:10.1111/csp2.13200 · Cited by 2
Morgan, J. C., Majors, J. E., & Galileo, D. S. (2005) · Clinical & Experimental Metastasis · doi:10.1007/s10585-005-6930-4 · Cited by 2
Src kinase: a therapeutic opportunity in endocrine-responsive and resistant breast cancer
Hiscox, S., & Nicholson, R. I. (2011) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.11.29 · Cited by 2
Genetische Grundlagen der Kanzerogenese
Bartram, C. R. (2009) · Springer eBooks · doi:10.1007/978-3-540-79725-8_4 · Cited by 4
Skopelitou, D., Miao, B., Srivastava, A., Kumar, A., Kuświk, M., Dymerska, D., Paramasivam, N., Schlesner, M., Lubiński, J., Hemminki, K., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11040262 · Cited by 2
“Even though post-translational modifications of the SRC protein have been widely studied as the underlying cause of high SRC activity in cancer, less is known about activating variation of the SRC gene in human CRC besides the somatic truncating mutation SRC 531 [57,58].”
The Cellular Microenvironment and Metastases
Giaccia, A. J., & Erler, J. T. (2008) · Elsevier eBooks · doi:10.1016/b978-0-443-06694-8.50006-3 · Cited by 2
Sawyer, T. K., Bohacek, R. S., Shakespeare, W. C., Metcalf, C. A., Wang, Y., Sundaramoorthi, R., Keenan, T. P., Narula, S. S., & Dalgarno, D. C. (2005) · Springer eBooks · doi:10.1007/0-387-24532-4_11 · Cited by 2
“, 1998), and the recent identification of activating Src mutations in advanced human colon cancer (Irby et al., 1999).”
BackgroundBoerner, J. L., Biscardi, J. S., & Parsons, S. J. (2005) · Wiley eBooks · doi:10.1002/0470025077.chap03 · Cited by 2
The fingerprints of the host innate immunity on the cells of primary virus-induced tumors
Deichman, G. I., Dyakova, N. A., Кашкина, Л. М., Матвеева, В. А., & Уварова, Э. Н. (2001) · Immunology Letters · doi:10.1016/s0165-2478(00)00304-7 · Cited by 2
Banerji, U., Judson, I. R., & Workman, P. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-734-5_1 · Cited by 2
Yeatman, T. J. (2003) · Wiley eBooks · doi:10.1038/npg.els.0001891 · Cited by 2
“More recently, a gene such as the SRC oncogene has also been identified as participating in the process of advanced tumour growth (Irby et al., 1999).”
BackgroundSelf-citationImmunohitochemical expression of p53 in human colocrectal carcinoma
Mirza, S. A., AL-Tai, T. H. H., & Shaker, H. H. (2016) · Journal of the Faculty of Medicine Baghdad · doi:10.32007/jfacmedbagdad.583266 · Cited by 1
Liu, Q., Yu, Y.-Y., & Wang, H. (2023) · PubMed Central · doi:10.30466/vrf.2022.552748.3454 · Cited by 1
Khanam, H., Dar, A. M., & Dar, B. A. (2025) · Arabian Journal for Science and Engineering · doi:10.1007/s13369-025-10660-6 · Cited by 1
Berdeli, A., Ismayilova, S., & Gürbüz, N. (2025) · Pediatric Rheumatology · doi:10.1186/s12969-025-01170-8 · Cited by 1
“Activating mutations in the COOH-terminal region of the c-Src gene have been associated with various diseases [25, 26].”
Madalageri, M., Sadashivanavar, V., Kinnal, R., Atchou, K., & Pai, K. S. R. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.154083 · Cited by 1
Signalling by the EGF receptor in human cancers: accentuate the positive, eliminate the negative
Bennett, H. L., Brummer, T., Timpson, P., Patterson, K., & Daly, R. J. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-356-1_17 · Cited by 1
p27 Regulation by Estrogen and Src Signaling in Human Breast Cancer
Slingerland, J. M. (2007) · Springer eBooks · doi:10.1007/978-3-540-73855-8_9 · Cited by 1
Alive failures behind the windows of cancer therapy
Islam, M. T. (2017) · International Journal of Medicine · doi:10.14419/ijm.v5i2.7035 · Cited by 1
Targeted Therapeutics in Cancer Treatment
Weekes, C. D., & Hidalgo, M. M. (2007) · Elsevier eBooks · doi:10.1016/b978-012372551-6/50072-9 · Cited by 1
Blaukat, A. (2007) · Elsevier eBooks · doi:10.1016/b978-008055232-3.60532-x · Cited by 1
Garnier, O., Jeanneret, F., Durand, A., Fertin, A., Berndt, S., Carpentier, G., Battail, C., Martin, D. K., & Vilgrain, I. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.125.323129 · Cited by 1
CIP4 and Src in Promoting the Migration and Invasion of Breast Cancers
Pichot, C. S. (2010) · Digital Commons-TMC (Texas Medical Center) · Cited by 1
The role of E-cadherin in colon cancer drug resistance.
Murray, L. J. (2010) · Enlighten: Theses (The University of Glasgow) · Cited by 2
Clinical Development of Src Family Kinase Inhibitors in Malignant Melanoma
Macpherson, I. R., Jones, R. J., & Evans, T. R. J. (2007) · The Open Cancer Journal · doi:10.2174/1874079000701010009 · Cited by 1
“A C-terminal truncating and activating Src mutation has been reported in a subset of colorectal cancers [32].”
BackgroundInvestigating the role of survivin in mitochondrial health
Townley, A. R. (2017) · Nottingham ePrints (University of Nottingham) · Cited by 1
Genetische Grundlagen der Kanzerogenese
Bartram, C. R. (2004) · Springer eBooks · doi:10.1007/978-3-662-06670-6_4 · Cited by 1
EGFRvIII Expression and Signaling in head and neck squamous cell carcinoma
Wheeler, S. E. (2012) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
Slap restricts oncogenic Src-family kinase signaling to maintain colonic epithelial homeostasisPreprint
Naim, D., HOUHOU, Z., Cauchois, F., Espie, K., Simon, V., Boublik, Y., Vives, F. L., Homayed, Z., Paul, C., Maillard, M., et al. (2026) · eLife · doi:10.7554/elife.110324 · Cited by 1
Competition between normal and transformed cell populations.
Moitrier, S. (2017) · theses.fr (ABES) · doi:10.70675/fd8dc785z700az460bzb0b5z9b5dc211e07c · Cited by 1
Colorectal cancer and defects in the mismatch repair and base excision repair systems
Enholm, S. (2004) · Helda - University of Helsinki Institutional Repository · Cited by 1
Intra-cellular tyrosine kinase
Irby, R., & Yeatman, T. J. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139046947.020
Self-citationMolecular Diagnosis of Hereditary Nonpolyposis Colorectal Cancer (HNPCC)
Loukola, A. (2000) · Helda - University of Helsinki Institutional Repository · Cited by 1
Targeted Therapeutics in Cancer Treatment
Weekes, C. D., & Hidalgo, M. M. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7358-0_15 · Cited by 1
A Role For Lipid Rafts In Egfr Tki Resistance In Breast Cancer
Irwin, M. E. (2010) · Human Biology
Regulation of bax activation and apoptosis by src and acetylated mutant p53
Woods, N. T. (2008) · Digital Commons - University of South Florida (University of South Florida)
Towards new therapeutic strategies in chondrosarcoma
Schrage, Y. M. (2009) · Leiden Repository (Leiden University)
The Crucial Role of c-Src Tyrosine Kinase in Bone Metabolism
Peruzzi, B., Rucci, N., & Teti, A. M. (2012) · InTech eBooks · doi:10.5772/37995
“Among several mechanisms proposed for increased c-Src activity in cancer, mutations resulting in constitutive activation of the kinase domain of the protein have been found in a subset of human cancers (Irby et al, 1999).”
BackgroundHamidi, A. (2015) · DiVA (Digitala Vetenskapliga Arkivet)
The role of Src kinase in renal cell carcinoma
Qayyum, T. (2014) · Enlighten: Theses (The University of Glasgow)
The Role of Genomic Instabilities in Affecting Treatment Responses of Colorectal Cancer
Ricciardiello, L., & Bazzoli, F. (2002) · Digestive Diseases · doi:10.1159/000063158
Glucocorticoids Modulate Transformation by v-Src in a Cell-Specific Manner
Provenzano, C., Alemà, S., & Falcone, G. (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5594
“Indeed, recently c-src mutations that result in activated, truncated forms or in very high expression of human c-Src have been identified in a number of human tumors [5, 6].”
BackgroundPredisposing and modifying genes in hereditary colorectal cancer syndromes
Moisio, A. (2002) · Työväentutkimus Vuosikirja
The 3' Untranslated Region of the Chicken c-src Protooncogene Modulates Gene Expression
Trejbalová, K., Plachý, J., Dezélée, P., Geryk, J., Svoboda, J., Calothy, G., & Hejnar, J. (2003) · Folia Biologica · doi:10.14712/fb2003049020051
GROWTH FACTOR AND SIGNAL TRANSDUCTION TARGETS FOR CANCER THERAPY
Leopold, W. R., Bridges, A. J., Decker, S. J., Fry, D. W., Kraker, A. J., & Sebolt, J. S. (2002) · Elsevier eBooks · doi:10.1016/b978-012072651-6/50004-8
DELETIONS IN THE DNA–BINDING DOMAIN OF THE TP53 GENE IN v-src–TRANSFORMED CHICKEN CELLS
Plachý, J., & Trtková, K. (2003) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1290/0312091.1
Pontillo, C. A. (2012) · Repositorio Digital Institucional de la Universidad de Buenos Aires (Universidad de Buenos Aires)
Src Family Tyrosine Kinases: Implications for Mammary Tumor Progression
Marcotte, R., & Muller, W. J. (2011) · Springer eBooks · doi:10.1007/978-0-387-69805-2_16
Trécesson, S. D. C. (2010) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 2
Kelley, L. C. (2010) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.3258
Novel binding partners of PBF in thyroid tumourigenesis
Sharma, N. (2014) · University of Birmingham Institutional Research Archive (University of Birmingham)
Activation of Oncogenic Protein Kinases
Martin, G. S. (2003) · Elsevier eBooks · doi:10.1016/b978-012124546-7/50437-x
Chung, D. C., & Podolsky, D. K. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6189-2.00003-2
Molecular genetic investigation into inherited thrombocytopenia
Johnson, B. (2017) · University of Birmingham Institutional Research Archive (University of Birmingham) · Cited by 2
Src Regulation of von Hippel-Lindau Tumour Suppressor Protein
Chou, M. T.-H. (2009) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/17055
Multidimensional Integration Analysis of Autophagy-related Modules in Colorectal Cancer
Zhang, Y., Zhang, Z., Wang, D., Xu, J., Li, Y., Wang, H., Li, J., Mo, S., Zhang, Y., Lin, Y., et al. (2018) · Letters in Organic Chemistry · doi:10.2174/1570178615666180914113224
Brain Metastasis of Colorectal Cancer: Microenvironment and Molecular Mechanism
Chen, Z., Gu, X., & Zang, Y.-W. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801419-6.00016-1
Berton, G. (2002) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1010015.141807
Nollau, P., & Mayer, B. J. (2002) · Wiley eBooks · doi:10.1002/0471203076.emm0528
c-Src Family of Tyrosine Kinases
Sen, B., & Johnson, F. M. (2012) · Springer eBooks · doi:10.1007/978-1-4419-0461-4_54
Yeatman, T. J. (2007) · Wiley eBooks · doi:10.1002/9780471743989.vse9861
Self-citationc-Src Family of Tyrosine Kinases
Sen, B., & Johnson, F. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-67199-4_54
Leroy, C., Fialin, C., Sirvent, A., Simon, V., Urbach, S., Poncet, J., Robert, B., Jouin, P., & Roche, S. (2023) · doi:10.1158/0008-5472.c.6499608.v1
Brunton, V. G., Avizienyte, E., Fincham, V. J., Serrels, B., Metcalf, C. A., Sawyer, T. K., & Frame, M. C. (2023) · doi:10.1158/0008-5472.c.6494636
Data from Srcasm Inhibits Fyn-Induced Cutaneous Carcinogenesis with Modulation of Notch1 and p53
Zhao, L., Li, W., Marshall, C. M., Griffin, T. W., Hanson, M., Hick, R. W., Dentchev, T., Williams, E. A., Werth, A. J., Miller, C. A., et al. (2023) · doi:10.1158/0008-5472.c.6500072
Data from Targeted Inhibition of Src Kinase Signaling Attenuates Pancreatic Tumorigenesis
Nagaraj, N. S., Smith, J. J., Revetta, F. L., Washington, M. K., & Merchant, N. B. (2023) · doi:10.1158/1535-7163.c.6531773
Data from Targeted Inhibition of Src Kinase Signaling Attenuates Pancreatic Tumorigenesis
Nagaraj, N. S., Smith, J. J., Revetta, F. L., Washington, M. K., & Merchant, N. B. (2023) · doi:10.1158/1535-7163.c.6531773.v1
Proteins-in-modules and genes-in-pieces. How proteins evolve
(2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99893-2.00005-1
Uncovering the Molecular Basis of Kinase Activity and Substrate Recognition With Phospho-PCAPreprint
Yu, C., Pao, E., & Valen, D. V. (2025) · SSRN Electronic Journal · doi:10.1101/2025.11.07.687244 · Cited by 2
Eldomery, M. K., Jones, K. M. D., Namwanje, M., Kumar, R. D., Li, J., Wilkinson, M. R., Wang, L., Klco, J. M., Li, T., Neary, J. L., et al. (2025) · medRxiv · doi:10.1101/2025.11.20.25340490
Nonreceptor Tyrosine Kinases and Their Roles in Cancer
Wiener, J. R., & Gallick, G. E. (2011) · Springer eBooks · doi:10.1007/978-1-4614-1216-8_4
Structural and functional characterization of the intrinsically disordered Unique domain of c-Src
Maffei, M. (2014) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Lim, J. E. (2023) · cIRcle (University of British Columbia) · doi:10.14288/1.0433726
Tyrosine kinase signalling pathways in pancreatic cancer
Tactacan, C. M. (2015) · UNSWorks (University of New South Wales, Sydney, Australia) · doi:10.26190/unsworks/18862
Lishak, J. (2019) · Nottingham ePrints (University of Nottingham)
Kock, L. D. (2021) · Lirias (KU Leuven)
Slap restricts oncogenic Src-family kinase signaling to maintain colonic epithelial homeostasis
Naim, D., HOUHOU, Z., Cauchois, F., Espie, K., Simon, V., Boublik, Y., Vives, F. L., Homayed, Z., Paul, C., Maillard, M., et al. (2026) · eLife · doi:10.64898/2026.01.05.697659
“However, SRC is rarely mutated in CRC and the mechanisms underlying its oncogenic function remain elusive (Irby et al., 1999; Sirvent et al., 2012; Summy and Gallick, 2003).”
Onuma, I., Iwata, Y., Zhou, Y., Nakada, M., Kondo, A., Iwahara, H., Natori, K., Yokoyama, S., Chihara, K., Takeuchi, K., et al. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.111200
“According to the TCGA database, more than 30% of human cancers harbor Src copy number gain, although there are a few activating mutations (5, 6).”
Signalisation oncogénique des tyrosine kinases et thérapies ciblées dans le cancer colorectal
Leroy, C. (2010) · theses.fr (ABES) · doi:10.70675/2ed0fd50z4cdfz44fazb610ze1e6911d3e30
Régulation de l'invasion cellulaire induite par les tyrosine kinases dans le cancer du sein
Chevalier, C. (2014) · theses.fr (ABES) · doi:10.70675/692c8de1za82az4e5ez953bz5e90670eb75d
Slap restricts oncogenic Src-family kinase signaling to maintain colonic epithelial homeostasisPreprint
Naim, D., HOUHOU, Z., Cauchois, F., Simon, V., Vives, F. L., Homayed, Z., Paul, C., Hahne, M., Pannequin, J., Nguyen, J., et al. (2026) · eLife · doi:10.7554/elife.110324.1
Price-Kuehne, F. E., Burleigh, A., Hong, Y., Omoyinmi, E., Petrof, G., Malik, G., McLellan, K. E., Owens, S., Lum, S. H., Dawson, P., et al. (2026) · Journal of Clinical Immunology · doi:10.1007/s10875-026-01998-z
“Somatic gain-of-function (GOF) variants in SFKs are well-established as key oncogenic drivers, and importantly, many of the signalling pathways that drive SFK-mediated oncogenesis are also fundamental to immune cell activation and cytokine production [6–8].”
Roles of substrate rigidity and composition in membrane trafficking
Wang, G. (2016) · theses.fr (ABES) · doi:10.70675/c94df204z301cz4442zb6a2z537e599ca027
New roles of the Lyn tyrosine kinase in psoriasis development and cell death
Diaz, L. E. A. (2018) · theses.fr (ABES) · doi:10.70675/3deccde8zd3dez40abzbda2ze9b04bfdfd62
Régulation de la signalisation de Src par son domaine N-terminal intrinsèquement désordonné
Aponte, E. (2018) · theses.fr (ABES) · doi:10.70675/28c1b781z0090z4f71zbca5z99055521b3ea
Importance de l'axe AhR/Src dans la reprogrammation des mélanomes métastasiques
Paris, A. (2021) · theses.fr (ABES) · doi:10.70675/aa73ebffz8914z40bazb170z7d5c3e02bc0f
Réponse biomécanique de cellules épithéliales à l'activation de l'oncoprotéine Src
Pricoupenko, N. (2022) · theses.fr (ABES) · doi:10.70675/6eda0cf3z001ez47c3z8f51z04ccf1b80992
Slap restricts oncogenic Src-family kinase signaling to maintain colonic epithelial homeostasisPreprint
Naim, D., HOUHOU, Z., Cauchois, F., Espie, K., Simon, V., Boublik, Y., Vives, F. L., Homayed, Z., Paul, C., Maillard, M., et al. (2026) · eLife · doi:10.7554/elife.110324.2
Naim, D., HOUHOU, Z., Cauchois, F., Espie, K., Simon, V., Boublik, Y., Vives, F. L., Homayed, Z., Paul, C., Maillard, M., et al. (2026) · eLife · doi:10.7554/elife.110324.2.sa0
Metadata
- Authors
- Irby, R. B., Mao, W., Coppola, D., Kang, J., Loubeau, J. M., Trudeau, W., Karl, R., Fujita, D. J., Jove, R., & Yeatman, T. J.
- Affiliations
- University of South Florida (US)
- University of Calgary (CA)
- Corresponding author
- Yeatman, Timothy J.
- Venue
- Nature Genetics
- Published
- 1999-02
- Volume
- 21
- Issue
- 2
- Pages
- 187-190
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- DOI
- 10.1038/5971
- OpenAlex
- W1594706458
- Cited by
- 489
- References
- 28
- Citations by year
- 2026: 9 · 2025: 7 · 2024: 2 · 2023: 11 · 2022: 1 · 2021: 5 · 2020: 9 · 2019: 13 · 2018: 9 · 2017: 9 · 2016: 12 · 2015: 15 · 2014: 19 · 2013: 12 · 2012: 21
- FWCI
- 11.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- TSpace (University of Toronto) (submittedVersion)
- Funders
- National Institutes of Health (5k11ca065512-03)
- National Cancer Institute (R01CA055652, CA-55652, CA65512)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Mechanisms and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- Src kinase, colon cancer, truncating mutations, non-receptor tyrosine kinase, oncogenic transformation, carcinogenesis, liver metastasis, malignant progression, Rous sarcoma virus
- MeSH terms
- Animals, Cell Line, Colonic Neoplasms, Humans, Liver Neoplasms, Lung Neoplasms, Mice, Inbred BALB C, Mice, Nude, Mutation, Neoplasm Transplantation, Transfection, Gene Expression Regulation, Neoplastic, Polymerase Chain Reaction, Genes, src, Proto-Oncogene Proteins pp60(c-src), 3T3 Cells, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.